https://scholars.lib.ntu.edu.tw/handle/123456789/586015
標題: | Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database | 作者: | CHIEN-CHANG LEE Hsu, Tzu-Chun Kuo, Chia-Chih Liu, Michael A Abdelfattah, Ahmed M Chang, Chia-Na MING YAO Li, Chi-Cheng Wu, Kang-Hsi Chen, Tsung-Chih Gau, Jyh-Pyng Wang, Po-Nan Liu, Yi-Chang Chiou, Lun-Wei Lee, Ming-Yang Li, Sin-Syue Chao, Tsu-Yi SHIANN-TANG JOU HSIU-HAO CHANG |
關鍵字: | Hematopoietic cell transplant; Least absolute shrinkage and selection operator; Post-transplant lymphoproliferative disorder; Predictive scoring system | 公開日期: | 10-九月-2021 | 來源出版物: | The oncologist | 摘要: | We externally validated Fujimoto's post-transplant lymphoproliferative disorder (PTLD) scoring system for risk prediction by using the Taiwan Blood and Marrow Transplant Registry Database (TBMTRD) and aimed to create a superior scoring system using machine learning methods. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/586015 | ISSN: | 10837159 | DOI: | 10.1002/onco.13969 | SDG/關鍵字: | busulfan; cyclophosphamide; fludarabine; thymocyte antibody; acute lymphoblastic leukemia; acute myeloid leukemia; adult; aplastic anemia; Article; bone marrow transplantation; chronic lymphatic leukemia; chronic myeloid leukemia; coronary artery bypass graft; demography; diagnostic procedure; female; graft versus host reaction; hematologic disease; hematopoietic stem cell transplantation; hematopoietic system malignancy; Hodgkin disease; human; human cell; human experiment; immunosuppressive treatment; laboratory test; major clinical study; male; multiple myeloma; myelodysplastic syndrome; myeloproliferative disorder; nonhodgkin lymphoma; patient registry; peripheral blood stem cell; posttransplant lymphoproliferative disease; prediction; prospective study; pulmonary veno-occlusive disease; receiver operating characteristic; risk assessment; scoring system; sensitivity and specificity; survival; thalassemia major; umbilical cord blood; validation study; adverse event; hematopoietic stem cell transplantation; lymphoproliferative disease; methodology; register; risk factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoproliferative Disorders; Registries; Research Design; Risk Factors |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。